Growth Factor Cocktail Including Fibroblast Growth Factor 9 in the Treatment of Androgenetic Alopecia in Men and Women: A Randomized Controlled Trial

A study involving 16 men and women evaluated the effectiveness of Cellcurin, a growth factor cocktail, in treating Androgenetic Alopecia (AGA). The treatment was administered via microneedling, and compared to a control group of 4 patients who received microneedling with 0.5% minoxidil. After 12 weeks, women in the treatment group showed an 86.96% increase in hair per cm2 in the frontal area and 59.52% in the vertex area. Men in the treatment group showed a 46.72% increase in the frontal area and 50.80% in the vertex region. Both genders also saw a significant increase in terminal hair diameters per cm2. The study concluded that Cellcurin therapy via microneedling effectively treats AGA by increasing hair density and thickness. The study also suggested that gender and racial differences may affect treatment effectiveness.